These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37129665)

  • 1. Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination.
    Shete PB; Tang AS; Flood J
    JAMA; 2023 May; 329(17):1457-1459. PubMed ID: 37129665
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of migration on tuberculosis in the United States.
    Menzies NA; Hill AN; Cohen T; Salomon JA
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1392-1403. PubMed ID: 30606311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis.
    Pareek M; Watson JP; Ormerod LP; Kon OM; Woltmann G; White PJ; Abubakar I; Lalvani A
    Lancet Infect Dis; 2011 Jun; 11(6):435-44. PubMed ID: 21514236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Introduction-Epidemiology of latent and active tuberculosis].
    Maitre T; Robert J; Veziris N
    Rev Mal Respir; 2018 Oct; 35(8):859-861. PubMed ID: 30241683
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening immigrants for latent tuberculosis: do we have the resources?
    Campbell J; Marra F; Cook V; Johnston J
    CMAJ; 2014 Mar; 186(4):246-7. PubMed ID: 24468691
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.
    Marks SM; Dowdy DW; Menzies NA; Shete PB; Salomon JA; Parriott A; Shrestha S; Flood J; Hill AN
    Public Health Rep; 2020; 135(1_suppl):38S-43S. PubMed ID: 32735183
    [No Abstract]   [Full Text] [Related]  

  • 7. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States.
    Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL
    Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
    Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
    JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Latent TBC in children is an increasing health problem. A retrospective study of medical records shows the need of health examination of new immigrants].
    Buxbaum L; Just M; Bergström SE; Blennow M
    Lakartidningen; 2011 Oct 26-Nov 1; 108(43):2157-60. PubMed ID: 22167978
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis: a forgotten plague?
    Keal JL; Davies PD
    J R Soc Med; 2011 May; 104(5):182-4. PubMed ID: 21558094
    [No Abstract]   [Full Text] [Related]  

  • 11. [Migration and Tuberculosis].
    Othmer JT; Schönfeld N; Häcker B; Otto-Knapp R; Bauer TT
    Pneumologie; 2018 Sep; 72(9):644-659. PubMed ID: 30165712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overseas Treatment of Latent Tuberculosis Infection in US-Bound Immigrants.
    Khan A; Phares CR; Phuong HL; Trinh DTK; Phan H; Merrifield C; Le PTH; Lien QTK; Lan SN; Thoa PTK; Thu LTM; Tran T; Tran C; Platt L; Maloney SA; Nhung NV; Nahid P; Oeltmann JE
    Emerg Infect Dis; 2022 Mar; 28(3):582-590. PubMed ID: 35195518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is screening immigrants for latent tuberculosis cost-effective?
    Mandalakas AM; Menzies D
    Lancet Infect Dis; 2011 Jun; 11(6):418-9. PubMed ID: 21616450
    [No Abstract]   [Full Text] [Related]  

  • 14. Think Globally, Act Locally: Diagnosis and Management of Latent Tuberculosis in Minnesota's Foreign-Born Population.
    Goers M; Settgast A
    Minn Med; 2015 Sep; 98(9):49-52. PubMed ID: 26442358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and treating tuberculosis in immigrants to the USA.
    Nelson R
    Lancet Infect Dis; 2014 Jun; 14(6):454-5. PubMed ID: 24971447
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
    Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
    Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priorities for screening and treatment of latent tuberculosis infection in the United States.
    Linas BP; Wong AY; Freedberg KA; Horsburgh CR
    Am J Respir Crit Care Med; 2011 Sep; 184(5):590-601. PubMed ID: 21562129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of tuberculosis in children].
    Delacourt C
    Rev Prat; 2012 Apr; 62(4):504-6. PubMed ID: 22641891
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric tuberculosis immigration screening in high-immigration, low-incidence countries.
    Alvarez GG; Clark M; Altpeter E; Douglas P; Jones J; Paty MC; Posey DL; Chemtob D
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1530-7. PubMed ID: 21144237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Priorities for Testing and Treatment of Latent Tuberculosis Infection in the United States.
    Martinez L; Andrews JR
    Clin Infect Dis; 2021 Nov; 73(9):e3483-e3485. PubMed ID: 32588882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.